Skip to Content
Merck

ABCs of Neonatal Cardiac Anesthesia.

Artificial organs (2013-01-12)
Chris Chin
ABSTRACT

Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and neonates are especially vulnerable. In order to manage these patients, a clear understanding of the underlying pathophysiology and the planned surgical procedure is important. However, attention to detail and meticulous care are equally important, and, in addition, there are several management strategies that may standardize practice and can improve outcome.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Magnesium sulfate heptahydrate, BioUltra, ≥99.5% (KT)
Sigma-Aldrich
Magnesium sulfate heptahydrate, BioReagent, for molecular biology, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
Magnesium sulfate heptahydrate, BioXtra, ≥99.0%
Sigma-Aldrich
Magnesium sulfate heptahydrate, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Magnesium sulfate heptahydrate, ACS reagent, ≥98%
Sigma-Aldrich
Magnesium sulfate solution, BioUltra, for molecular biology
Sigma-Aldrich
Magnesium sulfate, ≥99.99% trace metals basis
Sigma-Aldrich
Magnesium sulfate solution, for molecular biology, 1.00 M±0.04 M
Sigma-Aldrich
Magnesium sulfate, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Magnesium sulfate, puriss. p.a., drying agent, anhydrous, ≥98.0% (KT), powder (very fine)
Sigma-Aldrich
Magnesium sulfate, anhydrous, ReagentPlus®, ≥99.5%